Global dPCR Market Research Report 2019 (Includes Business Impact of COVID-19)

                                          
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the dPCR market.

Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the dPCR market."
Digital polymerase chain reaction (dPCR) technology is an advanced version of the polymerase chain reaction (PCR) technology that enables users to amplify and directly quantify nucleic acids, such as DNA, RNA, cDNA, and methylated DNA with a high level of precision. The technique allows users to statistically analyze PCR products by converting exponential, analog signals obtained from conventional PCR technology to linear and digital signals.
One of the primary drivers for this market is the rise in the focus on disease diagnosis and drug discovery and development. This increase in focus on medical research and drug discovery and development of several diseases is mainly driven by pharmaceutical and biotechnology companies as well as by research institutes. Also, it has been observed that governments of many developed and developing countries have been supporting research for new drug discovery and development. dPCR technology plays a vital role in drug discovery and development and for gene expression profiling, nucleic acid sequencing, and pharmacogenomics. Consequently, the major pharmaceutical and biotechnology companies will increase their adoption of dPCR technology due to high specificity, high accuracy, and productive results in developing new drug candidates. Such factors are expected to propel growth in the global dPCR market during the forecast period.
The global dPCR market is largely fragmented with the presence of many international and regional players present across the globe. The demand for dPCR solutions will be high in emerging countries, especially the BRIC countries (Brazil, Russia, India, China, and South Africa), due to an increase in their investments in drug research activities in various fields, including diagnosis of cancer. This rise is expected to intensify the competition among vendors in the next few years.

The global dPCR market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on dPCR volume and value at global level, regional level and company level. From a global perspective, this report represents overall dPCR market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    Bio-Rad Laboratories
    Fluidigm
    RainDance Technologies
    Thermo Fisher Scientific
    Becton
    Dickinson and Company
    Exiqon
    Formulatrix
    Promega Corporation
    Sigma-Aldrich
    Stilla Technologies

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    Consumables
    Instruments

Segment by Application
    Research Laboratories and Academic Institutes
    Pharma and Biotech Companies
    Hospitals and Diagnostic Centers
    Clinical Research Organizations
    Forensic Laboratories